Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines is seeking an experienced compliance leader in Europe to lead the development and implementation of organizational strategies, policies, and practices, and work with senior leadership to integrate appropriate healthcare, corporate, and other compliance controls to guide the company's operations.
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers.
Revolution Medicines